Lumbar Disc Disease Clinical Trial
Official title:
Injection of Autologous Bone Marrow Aspirate in Patients With Degenerative Disc Disease: a Phase I Clinical Trial
Lumbar discectomy and injection of purified cellular bone marrow concentrate or lumbar discectomy only
In order to find a regenerative treatment for back pain from DDD, cell based therapies have become of increasing interest. Recent clinical studies have shown promising improvement in pain and disc hydration, thus indicating a regenerative effect. The use of mesenchymal stem cells for regeneration of degenerated connective tissue of mesenchymal origin has proven efficient in multiple recent studies. However, the acquisition of mesenchymal stem cells (MSC) is always an extensive procedure requiring either enzymatic or genetic manipulation of acquired tissues. Thus, the use of these MSCs is highly controversial and raises concerns in terms of patient safety. One of the most commonly used sources for MSCs is bone marrow tissue. Even when not manipulated, these tissues already contain a significant amount of mesenchymal stem cells and growth factors. Therefore, they are used for regenerative treatments of multiple degenerative musculoskeletal diseases. This is an exploratory pilot study which aims to compare patient outcomes between two treatments approaches for DDD that are currently being used in clinic. While micro- discectomy is the standard of care for DDD, micro-discectomies with autologous bone marrow cell injections have been used in clinic in the past year. The goal of this study is to determine if the bone marrow injection group is superior compared to the control group (state of the art micro-discectomies) in enhancing degenerative disc recovery and improving or preventing back pain. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01941563 -
A Study of SI-6603 in Patients With Lumbar Disc Herniation
|
Phase 3 | |
Completed |
NCT04061759 -
Physiotherapy in Lumbar Disc Pathologies
|
N/A | |
Recruiting |
NCT04727385 -
Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease
|
N/A | |
Completed |
NCT04587401 -
The Effects of Anesthesia on Cerebral Perfusion in Patients With High Blood Pressure
|
N/A | |
Not yet recruiting |
NCT06034041 -
The Effect of Mediclore as an Anti-adhesion Agent and Safety in Full-endoscopic Spine Surgery: a Preliminary Study
|
Phase 4 | |
Recruiting |
NCT04134975 -
Evaluation of the Contribution of Intraoperative Scans Coupled With the Navigation for the Precision of the Positioning of the Pedicle Screws During a Lumbar Spine Surgery: a Prospective Randomised Study
|
N/A | |
Recruiting |
NCT04641039 -
Postoperative Scar in the Control Excess of Mobility Induced by Annulus Removal on Inserting a Lumbar Disc Prosthesis
|
N/A | |
Completed |
NCT04301232 -
Fast-Track Eligibility and Hospital Discharge for Outpatient Lumbar Discectomy
|
||
Recruiting |
NCT06154005 -
OsteoAdapt SP Advanced Bone Graft Feasibility Study - Transforaminal Interbody Lumbar Fusion
|
Phase 1/Phase 2 | |
Completed |
NCT03977961 -
The Six-Minute Walking Test (6MWT) as a Measure of Functional Impairment in Lumbar Degenerate Disc Disease.
|
||
Enrolling by invitation |
NCT05444751 -
GA + ESP vs. SA + ESP in Lumbar Decompression Surgeries
|
Phase 3 | |
Completed |
NCT02700451 -
Post-op Acetaminophen vs NSAID Use on Lumbar Spinal Fusion Outcomes
|
N/A | |
Completed |
NCT02421601 -
A Study of SI-6603 in Patients With Lumbar Disc Herniation
|
Phase 3 | |
Active, not recruiting |
NCT03733626 -
Clinical Outcomes Associated With the Use of ViviGen® for the Treatment of Lumbar Degenerative Disc Disease
|
N/A | |
Recruiting |
NCT04042844 -
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
|
Phase 2 | |
Recruiting |
NCT06462729 -
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
|
Phase 1/Phase 2 | |
Completed |
NCT05345249 -
Erector Spinae Plane Block as Pain Management After Lumbar Fusion Surgery
|
Phase 4 | |
Active, not recruiting |
NCT03060434 -
Pentoxifylline and Lumbar Radiculopathy
|
Phase 4 | |
Withdrawn |
NCT02852187 -
Single Center Study Comparing MOBIS II ST vs MOBIS PEEK
|
N/A | |
Completed |
NCT04062942 -
The Six-Minute Walking Test (6WT) and Timed-Up-and-Go (TUG) Test as Measures of Objective Functional Impairment in Patients Undergoing Interlaminar or Transforaminal Epidural Steroid Injection for Lumbar Degenerative Disc Disease (DDD)
|